Cancer Prevention after Cancer: Changing the Paradigm-a Report from the American Society of Preventive Oncology

被引:17
|
作者
Campo, Rebecca A. [2 ]
Rowland, Julia H. [3 ]
Irwin, Melinda L. [4 ]
Nathan, Paul C. [5 ]
Gritz, Ellen R. [6 ]
Kinney, Anita Y. [1 ,2 ]
机构
[1] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA
[2] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
[3] NCI, Off Canc Survivorship, Div Canc Control & Populat Sci, NIH DHHS, Bethesda, MD 20892 USA
[4] Yale Univ, Sch Publ Hlth, New Haven, CT USA
[5] Hosp Sick Children, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada
[6] Univ Texas MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA
关键词
LONG-TERM SURVIVORS; BREAST-CANCER; PHYSICAL-ACTIVITY; CHILDHOOD-CANCER; 5-YEAR SURVIVORS; SUBSEQUENT NEOPLASMS; TEACHABLE MOMENT; LATE MORTALITY; NECK-CANCER; 1ST YEAR;
D O I
10.1158/1055-9965.EPI-11-0728
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The state of cancer survivorship science has made significant advances, yet there still remain knowledge gaps (Fig. 5). First, there is an overall need to continue establishing a robust evidence base. In childhood cancer survivorship, research is needed that shows the effectiveness of the screening and surveillance guidelines developed, how best to inform adult childhood cancer survivors of these guidelines, and ways to improve patient-provider communication about this care. In tobacco cessation, more research is needed to examine and document the adverse effects of tobacco use on cancer treatment and survival, particularly, mechanisms underlying effect of tobacco on chemotherapy and other emerging modalities. In addition, more research is needed on the effectiveness of cessation programs tailored to different types of cancer survivors (by disease, age, and gender) and the effective timing of such interventions. Finally, in the area of energy balance, more randomized controlled trials are needed to elucidate the mechanisms by which diet, weight, and physical activity are associated with recurrence and survival, and to examine more downstream processes, such as the direct effects on and interactions with genetic, epigenetic, and molecular markers. Survivorship issues in diverse populations (e.g., low income status, rural geographic locations, or ethnic minority populations) remain a largely unexplored area in cancer survivorship science. A potential area of disparity research in childhood cancer survivorship would be the effectiveness and uptake rates of the screening and surveillance guidelines in rural and other underserved geographic locations, where access to healthcare professionals that are knowledgeable of these guidelines may be particularly scarce. Important diversity issues in tobacco research may include the effects of continued smoking on cancer treatment in different ethnic minority populations, such as African Americans who have a higher incidence of more advanced head and neck squamous cell carcinoma and poorer survival (44, 45). Finally, energy balance research on effective interventions for underserved populations would increase the generalizability of survival benefits; for instance, among African American breast and colorectal cancer survivors with high mortality (46). For cancer survivorship science to continue advancing, transdisciplinary research is critical. New advances in genomics and questions of gene-environment interactions can help inform survivorship science of the most effective interventions in different survivor populations and lead to personalization of these to produce the most successful outcomes. Furthermore, we need to build our capacity to deliver effective interventions more broadly if we are to significantly reduce the incidence of cancer recurrence and second cancers, and enhance quality of life. The first step would be educating physicians about effective interventions, such as the importance of prioritizing attention to tobacco cessation among cancer patients and survivors, and the need for special cancer screening guidelines for specific subsets of adult survivors of childhood cancers. In the area of energy balance, as more evidence of survival benefits comes forth, these interventions could be readily prescribed to overweight or obese cancer survivors, just as cardiac rehabilitation is prescribed for cardiovascular patients. Finally, design of evidence-based interventions that can be readily incorporated into standard clinical and community settings will lead to wider dissemination that will help improve the lives of more cancer survivors. The increasing prevalence of cancer survivors underscores a need for clinicians and public health professionals to provide health promotion interventions in this population. We need to continue to expand the evidence base with regard to the following: (i) healthy behaviors to reduce risk for new or recurrent cancers, maintain or improve health and quality of life, and (ii) early detection or guidelines for childhood cancer survivors to increase likelihood of survival with new or recurrent cancers. It is never too late for cancer survivors - or their healthcare providers - to make these changes. ©2011 American Association for Cancer Research.
引用
收藏
页码:2317 / 2324
页数:8
相关论文
共 50 条
  • [1] Job Satisfaction in Cancer Prevention and Control: A Survey of the American Society of Preventive Oncology
    O'Neill, Suzanne C.
    Thompson, Cheryl L.
    Kapp, Julie M.
    Worthington, Julie L.
    Graves, Kristi D.
    Madlensky, Lisa
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (08) : 2110 - 2112
  • [2] The characteristics and training of professionals in cancer prevention and control: A survey of the American Society for Preventive Oncology
    Chang, S
    Buist, DSM
    Reid, M
    Terry, MB
    Trentham-Dietz, A
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (07) : 1094 - +
  • [3] Cancer prevention and the American Society of Clinical Oncology
    Lippman, SM
    Levin, B
    Brenner, DE
    Gordon, GB
    Aldige, CR
    Kramer, BS
    Garber, JE
    Hawk, E
    Ganz, PA
    Somerfield, MR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) : 3848 - 3851
  • [4] Conducting Cancer Control and Survivorship Research via Cooperative Groups: A Report from the American Society of Preventive Oncology
    Palesh, Oxana
    Demark-Wahnefried, Wendy
    Mustian, Karen
    Minasian, Lori
    Rowland, Julia
    Sprod, Lisa
    Janelsins, Michelle
    Peppone, Luke
    Sloan, Jeff
    Engquist, Karen Basen
    Jones, Lee
    Buist, Diana
    Paskett, Electra D.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (05) : 1050 - 1055
  • [5] Undertaking Cancer Research in International Settings: Report from the American Society for Preventive Oncology Special Interest Group on International Issues in Cancer
    Wernli, Karen J.
    Kitahara, Cari M.
    Tamers, Sara L.
    Al-Temimi, Mohammed H.
    Braithwaite, Dejana
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (09) : 1638 - 1641
  • [6] Barriers to a Career Focus in Cancer Prevention: A Report and Initial Recommendations From the American Society of Clinical Oncology Cancer Prevention Workforce Pipeline Work Group
    Fabian, Carol J.
    Meyskens, Frank L., Jr.
    Bajorin, Dean F.
    George, Thomas J., Jr.
    Jeter, Joanne M.
    Khan, Shakila
    Tyne, Courtney A.
    William, William N., Jr.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02) : 186 - +
  • [7] Report from American Society of Clinical Oncology Symposium 2020 and American Society of Clinical Oncology Gastrointestinal Cancer Symposium 2021
    You, Y. Nancy
    Dasari, Arvind
    Chang, George J.
    [J]. DISEASES OF THE COLON & RECTUM, 2022, 65 (01) : 8 - 10
  • [8] Clinical cancer advances 2006: Major research advances in cancer treatment, prevention, and screening - A report from the American Society of Clinical Oncology
    Ozols, Robert F.
    Herbst, Roy S.
    Colson, Yolonda L.
    Gralow, Julie
    Bonner, James
    Curran, Walter J., Jr.
    Eisenberg, Burton L.
    Ganz, Patricia A.
    Kramer, Barnett S.
    Kris, Mark G.
    Markman, Maurie
    Mayer, Robert J.
    Raghavan, Derek
    Reaman, Gregory H.
    Sawaya, Raymond
    Schilsky, Richard L.
    Schuchter, Lynn M.
    Sweetenham, John W.
    Vahdat, Linda T.
    Winn, Rodger J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) : 146 - 162
  • [9] Clinical cancer advances 2007: Major research advances in cancer treatment, prevention, and screening - A report from the American Society of Clinical Oncology
    Gralow, Julie
    Ozols, Robert F.
    Bajorin, Dean F.
    Cheson, Bruce D.
    Sandler, Howard M.
    Winer, Eric P.
    Bonner, James
    Demetri, George D.
    Curran, Walter, Jr.
    Ganz, Patricia A.
    Kramer, Barnett S.
    Kris, Mark G.
    Markman, Maurie
    Mayer, Robert J.
    Raghavan, Derek
    Ramsey, Scott
    Reaman, Gregory H.
    Sawaya, Raymond
    Schuchter, Lynn M.
    Sweetenham, John W.
    Vahdat, Linda T.
    Davidson, Nancy E.
    Schilsky, Richard L.
    Lichter, Allen S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) : 313 - 325
  • [10] Clinical cancer advances 2005: Major research advances in cancer treatment, prevention, and screening - A report from the American Society of Clinical Oncology
    Herbst, RS
    Bajorin, DF
    Bleiberg, H
    Blum, D
    Hao, D
    Johnson, BE
    Ozols, RF
    Demetri, GD
    Ganz, PA
    Kris, MG
    Levin, B
    Markman, M
    Raghavan, D
    Reaman, GH
    Sawaya, R
    Schuchter, LM
    Sweetenham, JW
    Vahdat, LT
    Vokes, EE
    Winn, RJ
    Mayer, RJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) : 190 - 205